News

A Phase I clinical trial beginning this month in Kericho, Kenya and later in Tanzania and Uganda, will evaluate a new vaccine combination.

This small clinical trial will evaluate extended boosting regimens using the same vaccine components that were used in RV144.

Researchers have discovered important clues about the immune responses that may have played a role in protecting some volunteers from HIV in the RV144 Thai trial.

See what MHRP researchers presented at this annual conference, which draws leading scientists from around the world.

Meet Dr. Milton Omondi, Program Director of the Walter Reed Project (WRP) HIV/AIDS Program, Kisumu West (Kenya)

Dr. Doug Shaffer, Director of the Walter Reed Project–Kenya received both the Meritorious Civilian Service Award and Membership in the Order of Military Medical Merit.